Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTRX Turn Therapeutics (Direct Listing)

交易中 07-23 12:29:46 EDT

9.60

-0.02

-0.21%

最高9.75	最低9.50	成交量3.82万
今开9.52	昨收9.62	日振幅2.65%
总市值2.86亿	流通市值1.04亿	总股本2,979万
成交额36.43万	换手率0.35%	流通股本1,083万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTRX","market":"US","secType":"STK","nameCN":"Turn Therapeutics (Direct Listing)","latestPrice":9.6,"timestamp":1784824174783,"preClose":9.62,"halted":0,"volume":38164,"delay":0,"changeRate":-0.002079002079002035,"floatShares":10828400,"shares":29788040,"eps":-0.135345,"marketStatus":"交易中","change":-0.02,"latestTime":"07-23 12:29:46 EDT","open":9.5247,"high":9.75,"low":9.495,"amount":364326.825072,"amplitude":0.026507,"askPrice":9.64,"askSize":100,"bidPrice":9.34,"bidSize":55,"shortable":3,"etf":0,"ttmEps":-0.135345,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784836800000},"marketStatusCode":2,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":9.62,"preHourTrading":{"tag":"盘前","latestPrice":9.6,"preClose":9.62,"latestTime":"06:31 EDT","volume":1,"amount":9.6,"timestamp":1784802705025,"change":-0.02,"changeRate":-0.002079,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":9.62,"preClose":9.62,"latestTime":"19:34 EDT","volume":35,"amount":336.65,"timestamp":1784763246848,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.675586},"requestUrl":"/m/hq/s/TTRX","defaultTab":"news","newsList":[{"id":"1135575084","title":"Turn Therapeutics 公布特应性皮炎 Gx-03 二期项目最终第二阶段设计及数据驱动的扩展方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1135575084","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135575084?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:08","pubTimestamp":1783426120,"startTime":"0","endTime":"0","summary":"Turn Therapeutics 宣布了其针对特应性皮炎的 Gx-03 二期临床项目的最终第二阶段设计，并基于现有数据决定扩展该研究方案。这一进展标志着项目进入了新的关键实施阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156761829","title":"Turn Therapeutics中期分析显示：无治疗相关严重不良事件或停药报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1156761829","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156761829?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:36","pubTimestamp":1780317397,"startTime":"0","endTime":"0","summary":"Turn Therapeutics（直接上市）发布的中期分析数据显示，其研究在本次评估中未报告任何与治疗相关的严重不良事件，亦未出现受试者因治疗原因而中止参与的情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178696214","title":"Turn Therapeutics公布Gx-03二期试验中期分析结果及中重度特应性皮炎适应症优化策略","url":"https://stock-news.laohu8.com/highlight/detail?id=1178696214","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178696214?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:30","pubTimestamp":1780317034,"startTime":"0","endTime":"0","summary":"Turn Therapeutics公布了其针对中重度特应性皮炎的Gx-03二期临床试验的中期分析结果，并同步披露了一项适应性优化策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TTRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127224911","title":"Turn Therapeutics公司：预计全额融资收益将支持运营至2027年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1127224911","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127224911?lang=zh_cn&edition=full","pubTime":"2026-03-24 20:05","pubTimestamp":1774353911,"startTime":"0","endTime":"0","summary":"Turn Therapeutics公司近日宣布，通过完成全额融资所获得的收益，预计将足以支撑公司运营持续至2027年年底。这一资金规划为公司的长期发展提供了稳定的财务保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://turntherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.6672},{"period":"3month","weight":1.8716},{"period":"6month","weight":0.9794},{"period":"1year","weight":-0.038},{"period":"ytd","weight":1.4416}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Turn Therapeutics Inc.最初成立于2015年1月6日，是一家特拉华州有限责任公司。该公司是一家制药和医疗器械开发公司，其核心技术基于专有平台，旨在提升药物性能。其专利混合工艺——商业名称为 PermaFusion——能够在不使用乳化剂的情况下，将极性水溶性活性药物成分（“APIs”）稳定地悬浮在油性载体中。其主要开发项目专注于皮肤病，包括中度至重度湿疹和甲癣。","exchange":"NASDAQ","name":"Turn Therapeutics (Direct Listing)","nameEN":"Turn Therapeutics (Direct Listing)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Turn Therapeutics (Direct Listing)(TTRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Turn Therapeutics (Direct Listing),TTRX,Turn Therapeutics (Direct Listing)股票,Turn Therapeutics (Direct Listing)股票老虎,Turn Therapeutics (Direct Listing)股票老虎国际,Turn Therapeutics (Direct Listing)行情,Turn Therapeutics (Direct Listing)股票行情,Turn Therapeutics (Direct Listing)股价,Turn Therapeutics (Direct Listing)股市,Turn Therapeutics (Direct Listing)股票价格,Turn Therapeutics (Direct Listing)股票交易,Turn Therapeutics (Direct Listing)股票购买,Turn Therapeutics (Direct Listing)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Turn Therapeutics (Direct Listing)(TTRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}